NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ADC Development Panel, a specialized gene expression tool for use in the rapidly expanding field of Antibody Drug Conjugates (ADCs). Created in collaboration with leading pharmaceutical and clinical scientists, this novel panel is designed to provide molecular insights into important biological questions and challenges of oncology therapies.
Rumor: Is Disney About To Make A ‘Big’ NFT Acquisition?
Walt Disney Co (NYSE: DIS) is rumored to be making a big acquisition in the non fungible token (NFT) space, according to Outlier Ventures CEO Jamie Burke.
